Opening Recap
Market Pulse: Tech earnings beats and crypto snaps back, leaving markets staring at fresh run-ups after a muted stretch.
Key Movers: Zoom beat estimates, triggering a 4% bump (see Thefly.com), while Bitcoin and Ethereum shook off seven-month lows (The Times of India). MicroStrategy’s 50% pop fueled chatter around JPMorgan’s alleged short (newsBTC).
Macro & Politics: Shareholder transparency notifications (GlobeNewswire) and FDA approvals for Itvisma® (thefly.com; GlobeNewswire) hint at a regulatory environment that’s loosening and tightening in equal measure.
What’s Next: Eyes on SOL’s next retest and the options chain around MSTR for fresh momentum signals.
Unfiltered Market Commentary
Everyone’s missing a serious squeeze hazard in MSTR. JPMorgan allegedly built a massive short ahead of that surprise 50% spike—unless you’re eyeing the puts floods in “JPMorgan’s Alleged Short On Strategy (MSTR): How A 50% Price Jump Could Spell Major Troubles” (newsBTC), you’ll get blindsided by margin calls. It’s a damn setup for a classic gamma pinch.
Meanwhile, crypto’s shaking off seven-month lows—”Bitcoin continues recovery after hitting 7-month low, trades at $88K levels; Ethereum jumps 4%” (The Times of India) and “SOL rebounds alongside wider crypto market bounce: Is $160 possible?” (Cointelegraph)—while the FDA’s greenlighting gene therapies like Itvisma® (thefly.com; GlobeNewswire). Risk appetite is leaking into everything from BTC to biotech, and guess what: it flows into your bottom line if you ride it.
So here’s the call: lean into the volatility trade by scanning options chains on MSTR and SOL, and tuck a biotech stake behind FDA tailwinds. Also, watch those Transparency Notifications (GlobeNewswire) to spot hidden leverage before it pops. That’s where you strike, not just ride headlines.
📈 Breaking Financial News
Closing Bell Movers: Zoom up 4% on earnings beat
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corpor…
Novartis receives FDA approval for Itvisma
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corpor…
Novartis receives FDA approval for Itvisma®, the only gene replacement therapy for children two years and older, teens, and adults with spinal muscular atrophy (SMA)
Ad hoc announcement pursuant to Art. 53 LR Itvisma (onasemnogene abeparvovec-brve) demonstrated improved motor function and stabilization in patients……
JPMorgan’s Alleged Short On Strategy (MSTR): How A 50% Price Jump Could Spell Major Troubles
Strategy, formerly known as MicroStrategy, the largest public holder of Bitcoin (BTC), finds itself at the center of a stormy controversy involving JPMorgan as Bitcoin prices continue to struggle. With signs of a potential bear market emerging, fresh rumors …
Bitcoin continues recovery after hitting 7-month low, trades at $88K levels; Ethereum jumps 4%
Bitcoin rebounded from a 7-month low to trade near $88,000, gaining 2% in 24 hours as major altcoins also rallied. Ethereum jumped over 4%, while XRP, BNB, and Cardano rose 9%, 3% and 4%. Solana, Dogecoin and Hyperliquid gained up to 5%. Overall, global crypt…
Alert: The DeFi Token Set to Explode as Markets Recover Major institutions are f
This isn't speculation – this platform's role is so essential to crypto's financial system that its current price defies all logic. Just Released: The DeFi token set for massive gains as markets heat up – only $3!
🔍 Market Analysis & Insights
SOL rebounds alongside wider crypto market bounce: Is $160 possible?
SOL price rallied to $140, but weak derivatives market metrics and stagnate network fees show limited investor confidence. Is a retest of the $160 possible?
HIStalk Interviews James Lakes, President, Mednition
James Lakes, MSc is president of Mednition. Tell me about …
Pulsetto Vagus Nerve Stimulator Surpasses 100,000 Users Worldwide as Holiday Stress Season Drives Record Consumer Demand for Drug-Free Wellness Technology
Lithuanian-Made Bilateral Cervical Vagus Nerve Stimulator Surpasses 100,000 Global Users as Consumer Demand for Drug-Free Stress Relief, Sleep Support, and Relaxation Technology Reaches Record Levels During Holiday Wellness Season Lithuanian-Made Bilateral Ce…
Press release: Transparency Notification from Shareholders
Ghent, Nov. 24, 2025 (GLOBE NEWSWIRE) — Transparency Notification from Shareholders Ghent, Belgium – 24 November 2025 – Sequana Medical NV…
Gelteq Announces Positive Preclinical Results Demonstrating Enhanced Bioavailability Using Its Proprietary Gel-Based Drug Delivery Platform
Findings Anticipated to Unlock Broad New Commercial Opportunities Across Water-Soluble Drug Classes Findings Anticipated to Unlock Broad New Commercial Opportunities Across Water-Soluble Drug Classes
30 Million Ounces of Gold Just Moved to the U.S.
And It's Not a Coincidence… A historic gold transfer is underway – and according to 20-year gold analyst Garrett Goggin, it's a clear signal the global monetary system is about to change. Central Banks are already buying at record pace. But Goggin says four tiny miners are positioned for the biggest upside – with 100X potential as this “Golden Anomaly” unfolds. Click here to get all four picks before the window closes.
💰 Investment Opportunities
Waldencast Announces Q2 2025 Results and Provides Q3 2025 Trading Update
Transformation efforts drive performance improvements at Obagi Medical with accelerating revenue Contrasted performance for Milk Makeup with Q2 2025…
Sequana Medical Announces First U.S. Commercial alfapump® Implantation at Mount Sinai Hospital in New York
Ghent, Belgium, Nov. 24, 2025 (GLOBE NEWSWIRE) — Sequana Medical NV (Euronext Brussels: SEQUA, the “Company” or “Sequana Medical”), a pioneer in the treatment of drug-resistant fluid overload in liver disease, heart failure and cancer, today announced the su…
Michael Burry Takes On Nvidia And The AI Boom, Here's Why People Are Loving It
Michael Burry, famous for his accurate prediction of the mid-2000s US housing bubble burst, has once again stirred the pot in the financial world. This time,…
Crypto market’s weekly winners and losers – MYX, PI, DASH, STRK
This week, high-caps fell below key levels. Here’s a look at how some of your favorite coins fared.
Pulsetto Black Friday Sale: Vagus Nerve Stimulation Devices for Stress Relief Now Available at Promotional Pricing
Lithuanian-Made Cervical VNS Technology Reaches 100,000+ Users Worldwide as FCC-Certified Wellness Devices Gain Traction for Non-Pharmaceutical Stress Management and Sleep Support Lithuanian-Made Cervical VNS Technology Reaches 100,000+ Users Worldwide as FCC…
White House Insider Buck Sexton: “Trump's Next Move Will Shock the World”
dramatically increase U.S. power… and trigger a massive American market boom the likes of which we haven't seen in 75 years. Get the details here now.